Roche Appeals Ranbaxy Noninfringement Ruling

Law360, New York (October 26, 2009, 6:45 PM EDT) -- Roche Palo Alto LLC has decided to appeal a ruling that while its patent for Valcyte is valid, a generic version of the anti-viral drug made by Ranbaxy Laboratories Ltd. does not infringe it.

The drugmaker lodged a notice of its appeal of the Sept. 30 ruling from Judge Freda Wolfson of the U.S. District Court for the District of New Jersey on Friday.

In a detailed 92-page order, Judge Wolfson said that Ranbaxy had failed to prove that the patent in question was invalid and...
To view the full article, register now.